文献速递甲状腺疾病

生长分化因子15是癌细胞诱导的线粒体因子,可启动甲状腺癌细胞侵袭性

Growth Differentiation Factor 15 is a Cancer Cell-Induced Mitokine That Primes Thyroid Cancer Cells for Invasiveness.
PubMed 文献 · Thyroid · 2021-01-07

本研究探讨线粒体应激下甲状腺癌细胞诱导的线粒体因子GDF15是否赋予侵袭优势。在体外和体内模型中,线粒体氧化磷酸化抑制增加GDF15表达;266例甲状腺乳头状癌(PTC)患者中GDF15表达与肿瘤侵袭性相关,循环GDF15水平在PTC患者中显著高于对照。敲低GDF15可经STAT3调控降低甲状腺癌细胞活力、迁移和侵袭。

要点

  • 线粒体应激诱导甲状腺癌细胞表达GDF15。
  • PTC患者循环GDF15水平显著高于对照,肿瘤GDF15表达与侵袭性相关。
  • GDF15通过STAT3促进甲状腺癌细胞活力、迁移和侵袭。

核心结论

  • GDF15是甲状腺癌细胞在线粒体应激下诱导的线粒体因子。
  • GDF15诱导的STAT3活化决定甲状腺癌肿瘤进展。
  • GDF15-STAT3信号轴可能是甲状腺癌侵袭性的靶点。

研究设计与样本

  • 在体外和体内甲状腺癌模型中评估线粒体未折叠蛋白反应(UPRmt)及线粒体因子表达。
  • 用免疫组化检测266例甲状腺乳头状癌(PTC)患者的GDF15表达。
  • 检测健康受试者和PTC患者血清GDF15水平,并分析自有数据及癌症基因组图谱(TCGA)数据。
  • 在BCPAP、TPC-1、8505C和FRO细胞中观察GDF15敲低对肿瘤侵袭性的影响。

主要发现

  • 药物抑制甲状腺癌细胞线粒体氧化磷酸化功能可显著增加GDF15表达。
  • PTC患者中GDF15表达与线粒体整合应激反应通路激活相关。
  • PTC患者循环GDF15水平显著高于对照,肿瘤GDF15表达与肿瘤侵袭性相关。
  • 体外和体内敲低GDF15的甲状腺癌模型较对照细胞活力、迁移和侵袭降低,且经STAT3调控。

临床怎么用

  • GDF15-STAT3信号轴可能作为甲状腺癌侵袭性的干预靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Mitochondrial stress is known to activate the mitochondrial unfolded protein response (UPRmt). The UPRmt results in the secretion of mitochondrial cytokines (mitokines), which can promote a hormetic response cell nonautonomously, and has been reported to be protumorigenic. Growth differentiation factor 15 (GDF15) is a well-characterized mitokine, which is reported to have a mitohormetic effect. Thus, we investigated whether GDF15 induction could prime a subpopulation of thyroid cancer cells to provide invasive advantages. Methods: The UPRmt, including mitokine expression, was assessed in the context of thyroid cancer in vitro and in vivo. GDF15 expression in 266 patients with papillary thyroid carcinoma (PTC) was determined by immunohistochemistry. The serum levels of GDF15 were measured in healthy subjects and PTC patients. In addition, our own and The Cancer Genome Atlas data were analyzed to determine the expression level of GDF15 in thyroid cancers. The role of GDF15 in tumor aggressiveness was investigated by observing the effects of GDF15 knockdown in BCPAP, TPC-1, 8505C, and FRO cells. Results: Pharmacological inhibition of mitochondrial oxidative phosphorylation function in thyroid cancer cells robustly increased GDF15 expression. The expression of GDF15 was associated with activation of the mitochondrial integrated stress response pathway in PTC patients. Circulating GDF15 levels were significantly higher in PTC patients than in the controls, and tumor expression of GDF15 was related to tumor aggressiveness. In vitro and in vivo knockdown of GDF15 in a thyroid cancer model showed decreased viability, migration, and invasion compared with the control cells via regulation of STAT3. Conclusions: In this study, we demonstrated that GDF15 is a mitokine induced in thyroid cancer cells upon mitochondrial stress. GDF15-induced STAT3 activation determined tumor progression in thyroid cancer. The GDF15-STAT3 signaling axis may be a target in aggressiveness of thyroid cancer.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Kang YE, Kim JM, Lim MA, et al. Growth Differentiation Factor 15 is a Cancer Cell-Induced Mitokine That Primes Thyroid Cancer Cells for Invasiveness. Thyroid. 2021. PMID: 33256569. doi:10.1089/thy.2020.0034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。